Product Portfolio

The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.

RX

- Prescription Medicines

GABAPENTIN ARENA 300 mg

Anticonvulsant drug also indicated in the treatment of neuropathic pain

Capsules

300 mg

See details

GABAPENTIN ARENA 400 mg

Anticonvulsant drug also indicated in the treatment of neuropathic pain

Capsules

400 mg

See details

GLIBENCLAMIDA ARENA 1,75 mg

Oral antidiabetic from the sulfonylurea class, for blood glucose control in type 2 diabetes mellitus

Tablets

1,75 mg

See details

GLIBENCLAMIDA ARENA 3,5 mg

Oral antidiabetic from the sulfonylurea class, for blood glucose control in type 2 diabetes mellitus

Tablets

3,5 mg

See details

GLIBENCLAMIDA ARENA 5 mg

Oral antidiabetic from the sulfonylurea class, for blood glucose control in type 2 diabetes mellitus

Tablets

5 mg

See details

HALOPERIDOL ARENA 1 mg

Antipsychotic drug (neuroleptic) indicated in the treatment of schizophrenia and psychotic disorders

Tablets

1 mg

See details

HALOPERIDOL ARENA 2 mg

Antipsychotic drug (neuroleptic) indicated in the treatment of schizophrenia and psychotic disorders

Tablets

2 mg

See details

HALOPERIDOL ARENA 2 mg/ml

Antipsychotic drug (neuroleptic) indicated in the treatment of schizophrenia and psychotic disorders

Oral drops, solution

2 mg/ml

See details

INDOMETACIN ARENA 25 mg

Non-steroidal anti-inflammatory drug with strong action, indicated in arthritis, gout and rheumatic conditions

Capsules

25 mg

See details